| scholarly article | Q13442814 |
| P50 | author | Camilla Böckelman | Q50969187 |
| Caj Haglund | Q89637823 | ||
| P2093 | author name string | Mikael Lundin | |
| Ari Ristimäki | |||
| Jaana Hagström | |||
| Selja Koskensalo | |||
| P2860 | cites work | CIP2A expression is increased in prostate cancer | Q21198842 |
| Global cancer statistics | Q22241238 | ||
| CIP2A inhibits PP2A in human malignancies | Q24319683 | ||
| Genetic alterations during colorectal-tumor development | Q28281200 | ||
| Tissue microarrays for rapid linking of molecular changes to clinical endpoints | Q28365753 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis | Q34138056 | ||
| Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. | Q34138916 | ||
| Tissue microarray technology for high-throughput molecular profiling of cancer | Q34188970 | ||
| Colorectal cancer molecular biology moves into clinical practice | Q34425013 | ||
| Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). | Q34581206 | ||
| Genetic and epigenetic alterations in colon cancer | Q34762615 | ||
| MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. | Q34983172 | ||
| CIP2A is associated with human breast cancer aggressivity | Q34996768 | ||
| High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer | Q35034737 | ||
| Prognostic role of CIP2A expression in serous ovarian cancer | Q35263210 | ||
| ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells | Q39569073 | ||
| CIP2A expression and localization in oral carcinoma and dysplasia. | Q39597175 | ||
| International trends in colorectal cancer incidence rates | Q44546922 | ||
| CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation. | Q54393527 | ||
| P433 | issue | 5 | |
| P921 | main subject | colorectal cancer | Q188874 |
| overexpression | Q61643320 | ||
| P304 | page(s) | 289-295 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | CIP2A overexpression is associated with c-Myc expression in colorectal cancer. | |
| P478 | volume | 13 |
| Q38617799 | All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase |
| Q59329181 | Association Between c-Myc and Colorectal Cancer Prognosis: A Meta-Analysis |
| Q33895872 | Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis |
| Q47832427 | CIP2A expression and prognostic role in patients with esophageal adenocarcinoma |
| Q35009096 | CIP2A influences survival in colon cancer and is critical for maintaining Myc expression |
| Q39218849 | CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma |
| Q38401447 | CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis |
| Q39098575 | CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion |
| Q37428639 | Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity. |
| Q38710692 | Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibition |
| Q35755402 | Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma |
| Q39330291 | Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1. |
| Q43448302 | Clinical implications of CIP2A protein expression in breast cancer |
| Q38335027 | Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers |
| Q57787658 | Combined epithelial marker analysis of tumour budding in stage II colorectal cancer |
| Q58732759 | ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer |
| Q93160147 | Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer |
| Q36777896 | Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells |
| Q47110572 | High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosis |
| Q50876945 | Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma. |
| Q38891984 | Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells |
| Q35148539 | N-glycomic profiling as a tool to separate rectal adenomas from carcinomas. |
| Q54116955 | Nucleoside diphosphate kinase B promotes osteosarcoma proliferation through c-Myc. |
| Q38228491 | Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands |
| Q90467182 | Prognostic significance of CIP2A expression in solid tumors: A meta-analysis |
| Q50019901 | Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer |
| Q38103646 | Protein phosphatase 2A: a target for anticancer therapy |
| Q48044781 | Quadruplex DNA-Stabilising Dinuclear Platinum(II) Terpyridine Complexes with Flexible Linkers. |
| Q34309021 | REG4 independently predicts better prognosis in non-mucinous colorectal cancer |
| Q41922459 | Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism. |
| Q41160985 | The association and prognostic relevance of cancerous inhibitor of protein phosphatase 2A and inflammation in tongue squamous cell carcinoma |
| Q57808318 | The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers |
| Q91578408 | The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation |
| Q36844279 | Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer. |
| Q64964297 | c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients. |
Search more.